Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xuesaitong soft capsule in non-ischemic retinal vein occlusion
CTR20170349Phase 2Active
- Sponsor
- China Resources Kunming Shenghuo Pharmaceutical Co., Ltd.
- Start
- May 2017
- Countries
- 1
01
Overview
A Phase 2 trial of panax notoginseng in central retinal vein occlusion (CRVO), sponsored by China Resources Kunming Shenghuo Pharmaceutical Co., Ltd.. Started May 2017; status: active.
02
Drugs
panax notoginseng
03
Conditions
central retinal vein occlusion (CRVO)
Beyond the preview
Go deeper on CTR20170349.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20170349.